| |
Company
Roster
|
|
Total
Insiders : |
19 |
|
|
|
Total
Direct Shares :
|
10,817,845 |
|
|
Total
Indirect Shares :
|
2,610,561 |
| |
%
Held by Insiders:
|
4.16% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Selsavage Joseph Anthony |
Chief Financial & Actng Ofcr |
2024-05-21 |
2,258,390 |
2022-09-01 |
0 |
| Johnson Paul D |
VP, General Manager-Consumer |
2022-02-09 |
1,312,308 |
2021-11-01 |
0 |
| Abeec 2.0, Llc |
10% Owner |
2021-06-16 |
1,250,581 |
2021-06-16 |
2,500,000 |
| Lovell Evan |
Director |
2022-08-11 |
1,228,544 |
2021-09-14 |
0 |
| Hibbs Kathy L |
Chief Administrative Officer |
2024-05-20 |
1,217,033 |
2022-01-06 |
0 |
| Richards William G |
Head of Therapeutics Discovery |
2024-05-20 |
630,434 |
|
0 |
| Montgomery Rice Valerie Md |
Director |
2023-09-06 |
339,544 |
2021-09-14 |
0 |
| Hernandez Sandra R Md |
Director |
2023-09-06 |
337,549 |
2021-12-03 |
0 |
| Chung Patrick S |
Director |
2023-09-06 |
301,421 |
2021-09-14 |
0 |
| Lemon Steven |
Vice President, Engineering |
2022-02-09 |
270,374 |
2022-01-05 |
0 |
| Taylor Peter J. |
Director |
2023-09-06 |
265,217 |
2021-09-14 |
0 |
| Mohan Neal |
Director |
2023-09-06 |
245,806 |
2021-09-14 |
0 |
| Scheller Richard H |
Director |
2023-09-06 |
237,476 |
2021-09-14 |
0 |
| Hillan Kenneth |
Chief Therapeutics Officer |
2023-06-05 |
221,876 |
2022-02-09 |
0 |
| Schoch Steven J |
Chief Financial Officer |
2022-08-20 |
211,663 |
2022-02-09 |
0 |
| Botha Roelof |
Director, 10% Owner |
2023-09-06 |
193,379 |
2023-09-06 |
110,561 |
| Keim Tracy |
VP, Consumer Marketing & Brand |
2022-02-09 |
124,886 |
2022-02-09 |
0 |
| Brown Douglas R |
Director |
2020-10-06 |
100,000 |
2020-10-06 |
0 |
| Kohler Frederick Mark |
Vice President, People |
2022-02-09 |
71,364 |
2022-02-09 |
0 |
|
